Cargando…

Anticoagulation therapy in COVID-19: Is there a dose-dependent benefit?

Detalles Bibliográficos
Autores principales:	Kollias, Anastasios, Kyriakoulis, Konstantinos G., Syrigos, Nikolaos K., Stergiou, George S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771905/ https://www.ncbi.nlm.nih.gov/pubmed/33385796 http://dx.doi.org/10.1016/j.thromres.2020.12.013

Ejemplares similares

Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
por: Kollias, Anastasios, et al.
Publicado: (2021)

Cardiac injury and prognosis in COVID-19: Methodological considerations and updated meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2020)

Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2021)

Venous thromboembolism in COVID-19: A systematic review and meta-analysis
por: Kollias, Anastasios, et al.
Publicado: (2021)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)

COVID-19 and heart injury: Appropriate methodology is crucial for assessing the emerging evidence
por: Kollias, Anastasios, et al.
Publicado: (2020)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
por: Hsu, Andrew, et al.
Publicado: (2020)

Heparin failure and COVID-19: Should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care
por: Thomas, W., et al.
Publicado: (2020)

The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort
por: Lynn, Lei, et al.
Publicado: (2021)

Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021)

Clinical hypertension research in patients with atrial fibrillation: At last!
por: Kollias, Anastasios, et al.
Publicado: (2020)

Effect of therapeutic anticoagulation on gas exchange in mechanically ventilated COVID-19 patients: A secondary analysis of the COVID-HEP trial
por: Pantet, Olivier, et al.
Publicado: (2023)

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study
por: Ageno, Walter, et al.
Publicado: (2021)

Warfarin anticoagulation in the Covid-19 pandemic: Telephone-based management at a regional hematology outpatient center in Joinville, Brazil
por: Machado, Kendra Lys Calixto, et al.
Publicado: (2021)

A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic
por: Speed, V., et al.
Publicado: (2020)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients
por: Tsolaki, Vasiliki, et al.
Publicado: (2020)

The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
por: Kyriakoulis, Konstantinos G., et al.
Publicado: (2021)

Association of anticoagulation use with SARS-CoV2 detection()
por: Kavecansky, Juraj, et al.
Publicado: (2021)

Implementing Carotid Ultrasonography in Optimizing Primary Cardiovascular Prevention Strategy: Has the Time Come?
por: Kollias, Anastasios, et al.
Publicado: (2023)

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy
por: Daughety, Molly M., et al.
Publicado: (2020)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit
por: Vlot, E.A., et al.
Publicado: (2020)

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
por: Moll, Matthew, et al.
Publicado: (2021)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

Significant Increase in Blood Pressure Following BNT162b2 mRNA COVID-19 Vaccination among Healthcare Workers: A Rare Event
por: Syrigos, Nikolaos, et al.
Publicado: (2022)

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
por: Lawlor, Matthew, et al.
Publicado: (2021)

Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia()
por: Huang, Ching-Tai, et al.
Publicado: (2021)

High versus Standard Intensity of Thromboprophylaxis in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Kollias, Anastasios, et al.
Publicado: (2021)

COVID-19 associated pulmonary thrombosis
por: van Nieuwkoop, C.
Publicado: (2020)

Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
por: Nielsen, Nathan D., et al.
Publicado: (2022)

The long haul COVID-19 arterial thrombosis
por: Borrelli, Maria Pia, et al.
Publicado: (2022)

Association between Covid-19 and Pulmonary Embolism (AC-19-PE study)
por: Miró, Òscar, et al.
Publicado: (2020)

COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data
por: Choi, Sung-Hee, et al.
Publicado: (2022)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pqbn41rqi8gtufambkom4f2o6q